Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome

Neurology

Volumn 69, Issue 9, 2007, Pages 894-897

  Kozak, O S ^a   Wijdicks, E F M ^a   Manno, E M ^a   Miley, J T ^b   Rabinstein, A A ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPIN 2 ONE DERIVATIVE; CARBAMAZEPINE; FOSPHENYTOIN SODIUM; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; EPILEPTIC STATE; FEMALE; HUMAN; MALE; MONOTHERAPY; NEUROIMAGING; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; BLINDNESS, CORTICAL; BRAIN; BRAIN DISEASES; CHILD; CYCLOSPORINE; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAPHY; FEMALE; HEADACHE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; STATUS EPILEPTICUS; SYNDROME;

EID: 34548215692     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000269780.45472.16     Document Type: Article

References (14)

1. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
2. Striano P, Striano S, Tortora F, De Robertis E, Palumbo D, Elefante A, Servillo G. Clinical spectrum and critical care management of posterior reversible encephalopathy syndrome (PRES). Med Sci Monit 2005;11:CR549-CR553.
3. Lowenstein DH. Status epilepticus. West J Med 1998;168:263.
4. Kaplan PW. The clinical features, diagnosis, and prognosis of nonconvulsive status epilepticus. Neurologist 2005;11:348-361.
5. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;339:792-798.
6. Kaplan PW. Prognosis in nonconvulsive status epilepticus. Epileptic Disord 2000;2:185-193.
7. Bakshi R, Bates VE, Mechtler LL, Kinkel PR, Kinkel WR. Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings. Epilepsia 1998;39:295-299.
8. Lara N, Pascual I. Partial occipital seizures as main symptom of posterior encephalopathy secondary to immunosuppressants [in Spanish]. Neurologia 2006;21:269-274.
9. Natsume J, Sofue A, Yamada A, Kato K. Electroencephalographic (EEG) findings in posterior reversible encephalopathy associated with immunosuppressants. J Child Neurol 2006;21:620-623.
10. Szabo K, Poepel A, Pohlmann-Eden B, et al. Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus. Brain 2005;128:1369-1376.
11. Kassem-Moussa H, Provenzale JM, Petrella JR, Lewis DV. Early diffusion-weighted MR imaging abnormalities in sustained seizure activity. AJR Am J Roentgenol 2000;174:1304-1306.
12. Chu K, Kang DW, Kim JY, Chang KH, Lee SK. Diffusion-weighted magnetic resonance imaging in nonconvulsive status epilepticus. Arch Neurol 2001;58:993-998.
13. Lansberg MG, O'Brien MW, Norbash AM, Moseley ME, Morrell M, Albers GW. MRI abnormalities associated with partial status epilepticus. Neurology 1999;52:1021-1027.
14. Warach S, Levin JM, Schomer DL, Holman BL, Edelman RR. Hyperperfusion of ictal seizure focus demonstrated by MR perfusion imaging. AJNR Am J Neuroradiol 1994;15:965-968.